Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan and Lisinopril in Hypertensive Patients With Microalbuminuria
NCT00171067Phase 3Completed
- Sponsor
- Novartis
- Start
- Jul 2004
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of valsartan in hypertension (HTN) and Microalbuminuria (3 arms), sponsored by Novartis. Primary endpoint: Urinary Albumin Creatinine Ratio at 30 weeks. Started Jul 2004; status: completed.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)Microalbuminuria
Beyond the preview
Go deeper on NCT00171067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171067.